Is BPC-157 FDA approved? Status, what it is and tracking

Is BPC-157 FDA-approved?

No. BPC-157 isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.

Checked 23 Oct 2026. The sources are below.

BPC-157

Also: BPC 157, Bepecin, PL 14736, PL-10, PLD-116

Status label in the Peptimes Library: Not FDA-Approved
Routes in Peptimes: SubcutaneousOral
Updated: 25 Oct 2026

US regulatory status

FDA status
Not FDA-Approved. Drugs@FDA lists no application with BPC-157 as an active ingredient.
Source: Drugs@FDA, checked 23 Oct 2026

What studies have looked at

Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.

Review of studies
A 2025 systematic review of 36 studies (35 preclinical, in animals or the lab, and 1 in people) found that BPC-157 improved healing in animal injury models. The reviewers found no clinical safety data in humans.
Source: PMID 40756949, checked 27 Oct 2026
In humans
A placebo-controlled trial in 53 people with mild to moderate ulcerative colitis, reported as a 2005 meeting abstract. FDA judged the data inadequate to support either effectiveness or safety.
Source: FDA briefing document, July 2026, checked 27 Oct 2026
In humans
A retrospective review of people with knee pain: of the 12 who received BPC-157 alone, 11 reported improvement. The study had no control group and used no standard outcome measures.
Source: PMID 34324435, checked 27 Oct 2026
In humans
A pilot study in 12 women with interstitial cystitis that hadn't responded to another treatment: 10 reported their symptoms resolved and 2 reported partial relief. The study had no control group.
Source: PMID 39325560, checked 27 Oct 2026
In humans
A safety pilot in 2 adults reported no side effects and no change in standard blood tests. It had no control group and measured no drug levels.
Source: PMID 40131143, checked 27 Oct 2026

How to track it in Peptimes

The Library has two BPC-157 entries, and both show the status label “Not FDA-Approved”. “BPC-157” can be logged as subcutaneous or oral. “BPC-157 Oral” is oral only. Add the entry that matches your own records in My Protocols, and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose.

Logging: the amount you took, the route and how you feel.
Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Oral doses skip this step.
Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell BPC-157 or any other compound.

More sources

FDA, Global Substance Registration System, BPC-157, checked 23 Oct 2026: its sequence of 15 amino acids, and the names Bepecin, PL-14736 (written PL 14736 in the Peptimes Library), PL-10 and PLD-116.

Coming soon to the App Store

See planned pricing